Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin in Early Stage COVID-19
NCT04381884Phase 2Completed
- Sponsor
- Laboratorio Elea Phoenix S.A.
- Start
- May 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ivermectin in coronavirus disease 2019 (COVID-19), sponsored by Laboratorio Elea Phoenix S.A.. Started May 2020; status: completed.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04381884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04381884.